Treatment of Early Rheumatoid Arthritis in a Multinational Inception Cohort of Latin American Patients

Abstract

In this cohort of Latin American patients with early RA, most patients received MTX very early in their disease course. Combination therapy was used approximately in 1 of every 4 patients as initial therapy. Biologics were rarely used at this early stage, and low-dose prednisone was commonly used.